Page 1

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 10 - K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number : 001-39712 OLEMA PHARMACEUTICALS , INC . ( Exact name of Registrant as specified in its charter ) Delaware ( State or other jurisdiction of incorporation or organization ) 30-0409740 ( I.R.S. Employer Identification No. ) 512 2nd Street , 4th Floor San Francisco , California 94107 ( Address of principal executive offices and zip code ) Registrant's telephone number , including area code : ( 650 ) 243-5555 Securities registered pursuant to Section 12 ( b ) of the Act : Title of Each Class of Securities Registered Common Stock , par value $ 0.0001 per share Securities registered pursuant to Section 12 ( g ) of the Act : None Trading Symbol OLMA Name of Each Exchange on Which Registered The Nasdaq Global Select Market Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . YES □ NO Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Act . YES □ NO Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . YES NO Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( § 232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit such files ) . YES NO □ Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , a smaller reporting company , or an emerging growth company . See the definitions of " large accelerated filer , " " accelerated filer , " " smaller reporting company " and " emerging growth company " in Rule 12b - 2 of the Exchange Act . Large accelerated filer Non - accelerated filer ☑ Accelerated filer Smaller reporting company Emerging growth company ㅁ 囟 囟 If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . Indicate by check mark whether the registrant has filed report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 ( b ) of the Sarbanes - Oxley Act ( 15 U.S.C. 7262 ( b ) ) by the registered public accounting firm that prepared or issued its audit report . Indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Act ) . YES □ NO The aggregate market value of the common stock held by non - affiliates of the Registrant , based on the closing price of a share of common stock on November 19 , 2020 as reported by the Nasdaq Global Select Market on such date was approximately $ 520.8 million . The Registrant has elected to use November 19 , 2020 which was the initial trading date on the Nasdaq Global Select Market , as the calculation date because on June 30 , 2020 ( the last business day of the Registrant's most recently completed second fiscal quarter ) , the Registrant was a privately held company . This calculation does not reflect a determination that certain persons are affiliates of the Registrant for any other purpose . As of March 11 , 2021 , the number of outstanding shares of the Registrant's common stock , par value $ 0.0001 per share , was 40,169,738 . DOCUMENTS INCORPORATED BY REFERENCE Portions of the registrant's definitive Proxy Statement for the 2021 Annual Meeting of Stockholders to be filed with the U.S. Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this Annual Report on Form 10 - K are incorporated by reference in Part III , Items 10-14 of this Annual Report on Form 10 - K .